Find Ozagrel Hydrochloride manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

EU WC

EU WC

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 78712-43-3, Ozagrel hcl, Oky 046, 74003-18-2, Oky-046, (e)-3-(4-((1h-imidazol-1-yl)methyl)phenyl)acrylic acid hydrochloride
Molecular Formula
C13H13ClN2O2
Molecular Weight
264.71  g/mol
InChI Key
CWKFWBJJNNPGAM-IPZCTEOASA-N
FDA UNII
W222U960HS

Ozagrel Hydrochloride
1 2D Structure

Ozagrel Hydrochloride

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic acid;hydrochloride
2.1.2 InChI
InChI=1S/C13H12N2O2.ClH/c16-13(17)6-5-11-1-3-12(4-2-11)9-15-8-7-14-10-15;/h1-8,10H,9H2,(H,16,17);1H/b6-5+;
2.1.3 InChI Key
CWKFWBJJNNPGAM-IPZCTEOASA-N
2.1.4 Canonical SMILES
C1=CC(=CC=C1CN2C=CN=C2)C=CC(=O)O.Cl
2.1.5 Isomeric SMILES
C1=CC(=CC=C1CN2C=CN=C2)/C=C/C(=O)O.Cl
2.2 Other Identifiers
2.2.1 UNII
W222U960HS
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 3-(4-(1h-imidazol-1-ylmethyl)phenyl)-2-propenoic Acid

2. 4-(1-imidazoylmethyl)cinnamic Acid

3. Oky 046

4. Oky-046

5. Ozagrel

6. Ozagrel, Monohydrochloride

7. Ozagrel, Monohydrochloride, (e)-isomer

8. Sodium Ozagrel

2.3.2 Depositor-Supplied Synonyms

1. 78712-43-3

2. Ozagrel Hcl

3. Oky 046

4. 74003-18-2

5. Oky-046

6. (e)-3-(4-((1h-imidazol-1-yl)methyl)phenyl)acrylic Acid Hydrochloride

7. Chebi:31954

8. W222u960hs

9. Ozagrel (hydrochloride)

10. (e)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic Acid;hydrochloride

11. Dsstox_cid_25506

12. Dsstox_rid_80920

13. Dsstox_gsid_45506

14. Chembl542549

15. (2e)-3-[4-(1h-imidazol-1-ylmethyl)phenyl]-2-propenoic Acid Hydrochloride

16. Smr000469164

17. Sr-01000597793

18. Unii-w222u960hs

19. (2e)-3-(4-(1h-imidazol-1-ylmethyl)phenyl)-2-propenoic Acid Hydrochloride

20. (e)-3-(4-(1h-imidazol-1-ylmethyl)phenyl)-2-propenoic Acid Hydrochloride

21. Oky046 Hydrochloride

22. Cpd000469164

23. Ncgc00016937-01

24. Cas-78712-43-3

25. Oky-046 Hcl

26. Schembl36182

27. Schembl36183

28. Ozagrel Hydrochloride- Bio-x

29. Mls001401435

30. Mls002222319

31. Dtxsid9045506

32. Hy-b0428b

33. Hms1571c19

34. Hms3412f19

35. Hms3676f19

36. Ozagrel Hydrochloride [mi]

37. Bcp09493

38. Tox21_110693

39. S2067

40. Akos015895402

41. Ozagrel Hydrochloride [who-dd]

42. Tox21_110693_1

43. Ccg-100969

44. Nc00219

45. 2-propenoic Acid, 3-(4-(1h-imidazol-1-ylmethyl)phenyl)-, Monohydrochloride, (e)-

46. Ncgc00025195-06

47. Bo164219

48. Ds-11967

49. Ls-14196

50. B2116

51. Cs-0013156

52. O0419

53. Sw197369-4

54. Sr-01000597793-1

55. Sr-01000597793-4

56. Q27114733

57. Trans-4-[(1-imidazolyl)methyl]cinnamic Acid Hydrochloride

58. (e)-3-[4-(imidazol-1-ylmethyl)phenyl]propenoic Acid Hydrochloride

59. (2e)-3-{4-[(1h-imidazol-1-yl)methyl]phenyl}prop-2-enoic Acid Hydrochloride

2.4 Create Date
2006-04-28
3 Chemical and Physical Properties
Molecular Weight 264.71 g/mol
Molecular Formula C13H13ClN2O2
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count3
Rotatable Bond Count4
Exact Mass264.0665554 g/mol
Monoisotopic Mass264.0665554 g/mol
Topological Polar Surface Area55.1 Ų
Heavy Atom Count18
Formal Charge0
Complexity283
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Fibrinolytic Agents

Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)


Enzyme Inhibitors

Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)


Histamine Antagonists

Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. (See all compounds classified as Histamine Antagonists.)


REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty